GRMN
49
-9
BK
66
-5
AAP
29
-6
PYPL
58
-16
CB
44
-3
PLD
25
-5
RF
57
-9
ZTS
25
-9
LRCX
64
-3
AIG
54
-5
PSA
41
-2
PPG
37
-7
SYF
57
-8
MAT
43
-7
RCL
73
-6
NWSA
59
-5
NSC
60
-5
DHR
56
-6
MAR
57
-6
NTRS
59
-5
GRMN
49
-9
BK
66
-5
AAP
29
-6
PYPL
58
-16
CB
44
-3
PLD
25
-5
RF
57
-9
ZTS
25
-9
LRCX
64
-3
AIG
54
-5
PSA
41
-2
PPG
37
-7
SYF
57
-8
MAT
43
-7
RCL
73
-6
NWSA
59
-5
NSC
60
-5
DHR
56
-6
MAR
57
-6
NTRS
59
-5
Financhill
Back

Intellia Therapeutics Vs. Pacific Biosciences of California Industry Stock Comparison

Sell
27

NTLA
Intellia Therapeutics

Last Price:
$8.32
Seasonality Move:
19.08%
Buy
52

PACB
Pacific Biosciences of California

Last Price:
$1.21
Seasonality Move:
6.96%
Sell
27
Intellia Therapeutics (NTLA) is a Sell

Is Intellia Therapeutics a Buy, Sell or Hold?

  • The current Intellia Therapeutics [NTLA] share price is $8.31. The Score for NTLA is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • NTLA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Pacific Biosciences of California (PACB) is a Buy

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.20. The Score for PACB is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • PACB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NTLA Stock Price Chart

What is Intellia Therapeutics's stock price today?

  • The Intellia Therapeutics share price today is $8.31
    The current trend is relatively stagnant and NTLA is experiencing slight buying pressure.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PACB is experiencing buying pressure, which is a positive indicator for future bullish movement.

NTLA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 50.75 Buy
Chaikin Money Flow: 957647 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.62 - 9.12) Sell
Bollinger Bands (100): (7.55 - 10.23) Sell

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 58.73 Buy
Chaikin Money Flow: 4063643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.97 - 1.15) Buy
Bollinger Bands (100): (1.07 - 1.51) Sell

NTLA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.14 Buy
20-day SMA: 8.42 Sell
50-day SMA: 8.02 Buy
200-day SMA: 12.81 Sell
8-day EMA: 8.23 Buy
20-day EMA: 8.23 Buy
50-day EMA: 8.41 Sell
200-day EMA: 12.78 Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.13 Buy
20-day SMA: 1.05 Buy
50-day SMA: 1.13 Buy
200-day SMA: 1.58 Sell
8-day EMA: 1.14 Buy
20-day EMA: 1.1 Buy
50-day EMA: 1.15 Buy
200-day EMA: 1.77 Sell

Intellia Therapeutics Earnings Growth & NTLA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.39 per share, a decrease next quarter of $0.09 per share, an increase this year of $1.12 per share, and an increase next year of $0.30 per share.

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.18 per share, and an increase next year of $0.13 per share.

Intellia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):